Bruker BioSpin President Falko Busse to depart; separation includes ~$1M severance

BRUKER CORP

Falko Busse, Ph.D., to step down as President of Bruker BioSpin; duties transition May 1, 2026, employment ends Oct 31, 2026.
Separation agreement provides approximately $1,020,351 in severance, prorated bonus, and unused vacation payout.
Unvested equity awards as of Oct 31, 2026 will be forfeited per plan provisions.
Agreement includes non-compete, non-solicitation, non-disparagement, and confidentiality covenants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.